Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biopharmaceutical Statistics"
DOI: 10.1080/10543406.2022.2141769
Abstract: ABSTRACT Overall survival, progression-free survival, objective response/complete response, and duration of (complete) response are frequently used as the primary and secondary efficacy endpoints for designs and analyses of oncology clinical trials. However, these endpoints are… read more here.
Keywords: oncology; benefit outcomes; evidence; evidence synthesis ... See more keywords